You are here

• Home
• News

• 2009

• • 03 November 2009
  • AstraZeneca PLC Third Quarter & Nine Months Results 2009  
• • 21 October 2009
  • In the battle against cancer, ‘future progress depends on personalisation of healthcare’ says AstraZeneca Chief Executive  
• • 16 October 2009
  • Driving innovation through dynamic collaboration in Asia  
• • 17 September 2009
  • Phase III head to head trial showed BRILINTA reduced cardiovascular death and heart attacks over clopidogrel in Acute Coronary Syndromes patients.  
• • 09 September 2009
  • Collaboration in Innovation Drives to Future Success Ground-breaking Ceremony Held for AstraZeneca China Zhangjiang Site  
• • 06 July 2009
  • IRESSATM (GEFITINIB) RECEIVES MARKETING AUTHORISATION FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN EUROPE  
• • 16 May 2009
  • Run For A Better Tomorrow--2009 AstraZeneca-CIIC Charity Run Kicks Off on May.16th  
• • 06 May 2009
  • Research Fund Set up By State Key Lab of Respiratory Disease and AstraZeneca  
• • 06 April 2009
  • Expert Talk in Breast Cancer Care  
• • 06 April 2009
  • Harsh as the Situation of Lung Cancer is, Advanced Patients Have Taken the Favorable Turn  

Quick links

• Careers
• AstraZeneca iHeart
• AstraZeneca Anaesthesia
• AstraZeneca Arimidex
• AstraZeneca Seroquel
• AstraZeneca Corporate
• AstraZeneca Asia Pacific Anesthesia Innovator Awards Program

Page tools

• Print
• Bookmark this page